Personal information

Activities

Collapse all

Works (6)

Diversity in Oncology Clinical Trials: Current Landscape for Industry-Sponsored Clinical Trials in Asia

Oncology and Therapy
2024-03 | Journal article
DOI: 10.1007/s40487-023-00254-3
Contributors: Dany Habr; Manmohan Singh; Roberto Uehara
Source: check_circle
Crossref

Correction: Patients at the Heart of the Scientific Dialogue: An Industry Perspective

Oncology and Therapy
2023-03 | Journal article
DOI: 10.1007/s40487-023-00222-x
Contributors: Dany Habr; Brittany Wolf Gianares; Kristine W. Schuler; Dheepa Chari
Source: check_circle
Crossref

Patients at the Heart of the Scientific Dialogue: An Industry Perspective

Oncology and Therapy
2023-03 | Journal article
DOI: 10.1007/s40487-023-00220-z
Contributors: Dany Habr; Brittany Wolf Gianares; Kristine W. Schuler; Dheepa Chari
Source: check_circle
Crossref

Reimagining diversity in multiple myeloma clinical trials

Hematological Oncology
2022-10 | Journal article
DOI: 10.1002/hon.2997
Contributors: Dany Habr; Massimo Corsaro
Source: check_circle
Crossref

Age Is Just a Number: Considerations for Older Adults in Cancer Clinical Trials

JNCI: Journal of the National Cancer Institute
2021-11-02 | Journal article
DOI: 10.1093/jnci/djab070
Contributors: Dany Habr; Lynn McRoy; Vassiliki A Papadimitrakopoulou
Source: check_circle
Crossref

Addressing racial/ethnic disparities in cancer clinical trials: Everyone has a role to play

Cancer
2021-09-15 | Journal article
DOI: 10.1002/cncr.33600
Contributors: Dany Habr; Roxanne Ferdinand
Source: check_circle
Crossref

Peer review (1 review for 1 publication/grant)

Review activity for BMJ (1)
How many people are using ORCID?